Comprehensive Add on Study in Japan

Summary

The objective of the current study is to investigate the safety and efficacy of linagliptin (5mg / once daily) given for 52 weeks as add-on therapy to patients with type 2 diabetes mellitus and insufficient glycaemic control despite diet, exercise, and treatment with one approved antidiabetic drug.

Timeline

Start

2010-09

Primary completion

2012-01

Completion

2012-01

Drugs

Indications